Almirall ‘hit’ it off with Evotec in ion channel agreement
Anglo-German company Evotec is joining forces with Almirall to identify small molecule modulators of an ion channel target involved in respiratory diseases.
Chemically defined supplements boost Sheffield Bio-Science's product portfolio
Sheffield Bio-Science takes on responsibility for global sales, distribution and development of Girus Life Sciences’ chemically defined Regocel supplements.
Pfizer add $5m to TetraLogic’s cancer treating drug fund
TetraLogic Pharmaceuticals receives $5m (€3.7m) investment from Pfizer Ventures, helping fund clinical development of a drug that mimics naturally forming proteins, promoting cell death.
DSM seeks Asian partners; welcomes J&J Crucell takeover
DSM aims to keep pace with the rapid evolution of pharmaceutical sector through increased partnering and a focus on Asia.
EPO reengineered to cross mice BBB for neuroprotection
Reengineering erythropoietin (EPO) as an immunoglobulin G (IgG) fusion protein enables penetration of the blood-brain barrier (BBB) in mice, according to researchers.
DSM and PolyTherics forge biobetter manufacturing deal.
DSM’s microbial fermentation CMO business unit and UK-based biopharmaceutical company, PolyTherics, have formed an agreement to develop and manufacture PolyTherics’ lead ‘biobetter’ product, HiPEG IFN a-2a.
Life Technologies to out-license CHO cell lines recombinant proteins
Life Technologies has concluded license agreements, providing rights to its proprietary Chinese hamster ovary (CHO) cell lines for production of recombinant proteins used as therapeutic agents and vaccines.
North American HQ to facilitate growth, says Almac
In an exclusive Q&A Mark Rohlfing, Almac’s director of Quality, updates Outsourcing-pharma on the firm’s new North American HQ, growth plans and US recruitment drive.
J&J to buy Crucell for $2.3bn
Johnson & Johnson is in advanced talks to buy biotechnology firm Crucell to boost vaccine development and manufacturing capacity.
Biomanufacturing sales key to Pall’s Q4 growth
Pall has ended fiscal 2010 with strong set of sales after recovering pharmaceutical industry demand for bioproduction tech maintained its momentum in Q4
Q Chip scaling up cGMP production using new funding
Q Chip is using new funding to scale up its Q-Sphera technology for cGMP production of sustained release peptide and protein therapeutics.
NexACT enables rectal delivery of biologics, say Apricus Bio
Apricus Biosciences, formerly NexMed, announce preclinical data shows NexACT technology enables rectal delivery of biologics, including human antibodies.
Gentronix deal boosts CRL’s genotoxicity service offering
Charles River Laboratories (CRL) is strengthening its genotoxicity screening service by offering Gentronix’s BlueScreen HC.
Sanofi files sBLA with FDA for intradermal influenza vaccine
Sanofi Pasteur has filed a sBLA with the FDA for an intradermal form of influenza vaccine Fluzone using a microinjection system.
CLS’ new Toolkit aims to boost preclinical research
Living Image Multi-Modality Software Module and Mouse Imaging shuttle will widen the understanding of animal biology in preclinical research, say Caliper Life Sciences.